Rurelec rises on Chilean power firm deal

Latin America power generation company Rurelec rose strongly after it announced a deal to buy a 50 per cent stake in a Chilean firm.

Latin America power generation company Rurelec rose strongly after it announced a deal to buy a 50 per cent stake in a Chilean firm.

The company has agreed terms with Independent Power Corporation (IPC) to acquire its interest in Central Illapa.

The Chilean project company is developing a 250 MW open cycle gas fired peaking plant in Mejillones, a key hub on the Chilean power grid.

Rurelec is acquiring the shares in Central Illapa for zero premium and refunding a portion of its third party project costs to date.

The news boosted shares 9.5% by 0900 on Wednesday.

Central Illapa has also been shortlisted by an international mining group in a tender to supply 500 MW of power to their operations in northern Chile.

If awarded the power purchase agreement, Rurelec said it would work with substantial industry partners to construct, own and operate this high efficiency liquefied natural gas fired combined cycle gas turbine plant.

Rurelec and IPC have also together been short-listed for a further 500 MW CCGT project to be constructed in northern Chile also to run on LNG with capacity to be contracted to another mining group, the firm said.

The PPA proposals are scheduled to be adjudicated in the second or third quarters of 2013.

Peter Earl, Chief Executive of Rurelec, said the group's decision to focus on Chile and Peru came at a time when both countries urgently need new generation capacity.

He noted that regional mining companies were looking for reliable and experienced partners to meet the energy needs of their operations.

Recommended

Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Investing in drugmakers: uncommon profits from curing rare diseases
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022
Delivering profits: should you buy Royal Mail shares?
Share tips

Delivering profits: should you buy Royal Mail shares?

The volume of parcels delivered by Royal Mail soared during the pandemic, and so did its profits. But it has been coming under pressure lately. So, as…
19 May 2022

Most Popular

The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Aviva: a share for income investors to tuck away
Share tips

Aviva: a share for income investors to tuck away

Insurance giant Aviva is one of the highest yielding stocks in the FTSE 100 – and it’s cheap, too, making it a tempting target for income investors. R…
18 May 2022
Despite the crypto crash, bitcoin still has a bright future
Bitcoin & crypto

Despite the crypto crash, bitcoin still has a bright future

Cryptocurrencies have crashed hard, with bitcoin down by more than 50% from its peak. But, says Dominic Frisby, bitcoin still has a future – it is the…
19 May 2022